Tech Company Financing Transactions
CN Bio Innovations Funding Round
CN Bio Innovations, operating out of Cambridge, raised $21 million from Bayland Capital and private investors.
Transaction Overview
Company Name
Announced On
4/23/2024
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its product portfolio and to scale the business to support commercial expansion across key global markets.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Cambridge Science Park Milton Rd, Milton
Cambridge, CB4 0WN
UK
Cambridge, CB4 0WN
UK
Phone
Website
Email Address
Not Recorded
Overview
CN Bio is a leading organ-on-a-chip (OOC) company that enables researchers to improve the accuracy and efficiency of preclinical drug discovery. Our PhysioMimix® suite of microphysiological systems, 3D-validated cells, consumable plates, and Contract Research Services facilitate the prediction of human responses to drug exposure, in the presence or absence of disease, so that new medicines can be brought to market more rapidly, cost-effectively and using fewer animals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Brooks
Browse more venture capital transactions:
Prev: 4/23/2024: RockFi venture capital transaction
Next: 4/23/2024: Prophet Security venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs